Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma

NCT04813523 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of Esophagogastric Junction
Neoadjuvant Chemotherapy
Pembrolizumab

Interventions

DRUG: Pembrolizumab Injection [Keytruda]

Sponsor

Tianjin Medical University Cancer Institute and Hospital